Clinical Trial Update: A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma [Phase 1]

View source ↗

Summary

Phase 1 study of AIR645 in healthy subjects and subjects with controlled asthma has completed, reporting initial safety, tolerability, and pharmacokinetic data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AIR645

Snippet

Sponsor: Altair Therapeutics, Inc. | Conditions: Asthma | Phase 1 | Status: COMPLETED